The functional role in RA patients of these two soluble inhibitory receptors has not been investigated, although it is conceivable that whatever the source of these receptors, they can compete with the surface LAIR1 which in turn can be reduced by the release of the soluble molecules. Here, LAIR1 is linked to rheumatoid arthritis.